PAHC

No analysis generated yet. Run the pipeline for this company.

AI-extracted key facts from press releases and SEC filings. Significance 1–10.

6

EarningsBullishPer-CompanyApr 3, 2026

Phibro Animal Health Q2 Earnings and Revenue Beat Expectations on Vaccine Growth

▸Fiscal Q2 2026 earnings and revenue exceeded analyst expectations
▸FY2026 net sales guidance reaffirmed at $1.45B–$1.50B
▸FY2026 net income guidance reaffirmed at $85M–$95M
▸Vaccine portfolio and international markets driving long-term business mix shift
▸BFI Co., LLC sold 14,080 Class A shares via Rule 10b5-1 plan

Phibro Animal Health